Shorter telomeres in patients with cerebral autosomal dominant arteriopathy and leukoencephalopathy (CADASIL)

Neurogenetics

Volumn 12, Issue 4, 2011, Pages 337-343

  Ragno, Michele ^a   Pianese, Luigi ^a   Pinelli, Michele ^b   Silvestri, Serena ^a   Cacchiò, Gabriella ^a   Di Marzio, Fabio ^a   Scarcella, Maria ^a   Coretti, Francesco ^b   Altamura, Fabiana ^b   Monticelli, Antonella ^b,c   Castaldo, Imma ^b  

^a Mazzoni Hospital   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c CNR   (Italy)

Author keywords

CADASIL; Notch3 gene; Oxidative stress; Telomere

Indexed keywords

NOTCH3 RECEPTOR;

ADULT; AGED; ARTICLE; CADASIL; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; LEUKOCYTE; MALE; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TELOMERE;

ADULT; AGED; AGED, 80 AND OVER; CADASIL; FEMALE; HUMANS; MALE; MIDDLE AGED; TELOMERE; TELOMERE SHORTENING;

EID: 84855285309     PISSN: 13646745     EISSN: 13646753     Source Type: Journal    
DOI: 10.1007/s10048-011-0298-1     Document Type: Article

References (29)

1. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM (1994) Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 91:9857-9860 (Pubitemid 24311907)
2. Friedrich U, Griese E, Schwab M, Fritz P, Thon K, Klotz U (2000) Telomere length in different tissues of elderly patients. Mech Ageing Dev 119:89-99
3. Fitzpatrick AL, Kronmal RA, Gardner JP, Psaty BM, Jenny NS, Tracy RP, Walston J, Kimura M, Aviv A (2007) Leukocyte telomere length and cardiovascular disease in the Cardiovascular Health Study. Am J Epidemiol 165:14-21 (Pubitemid 46026204)
4. von Zglinicki T, Serra V, Lorenz M, Saretzki G, Lenzen-Grossimlighaus R, Gessner R, Risch A, Steinhagen-Thiessen E (2000) Short telomeres in patients with vascular dementia: an indicator of low antioxidative capacity and a possible risk factor? Lab Invest 80:1739-1747
5. Panossian LA, Porter VR, Valenzuela HF, Zhu X, Reback E, Masterman D, Cummings JL, Effros RB (2003) Telomere shortening in T cells correlates with Alzheimer's disease status. Neurobiol ageing 24:77-84
6. Razvi SS, Davidson R, Bone I, Muir KW (2005) The prevalence of cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) in the west of Scotland. J Neurol Neurosurg Psychiatry 76:739-741 (Pubitemid 40569692)
7. Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, Alamowitch S, Domenga V, Cécillion M, Marechal E, Maciazek J,Vayssiere C, Cruaud C, Cabanis EA, Ruchoux MM,Weissenbach J, Bach JF, BousserMG, Tournier-Lasserve E (1996) Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383:707-710 (Pubitemid 26360644)
8. Artavanis-Tsakonas S, Rand MD, Lake RJ (1999) Notch signaling: cell fate control and signal integration in development. Science 284:770-776 (Pubitemid 29291335)
9. Joutel A, Andreux F, Gaulis S, Domenga V, Cecillon M, Battail N, Piga N, Chapon F, Godfrain C, Tournier-Lasserve E (2000) The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J Clin Invest 105:597-605 (Pubitemid 30146506)
10. Di Maio G, Formichi P, Radi E, Bianchi S, Onnis A, Tarquini E, Leoncini L, Federico A. Human peripheral blood lymphocytes and fibroblasts as Notch3 expression models. J Cell Physiol 2011; doi: 10.1002/jcp.22901
11. Joutel A, Vahedi K, Corpechot C, Troesch A, Chabriat H, Vayssière C, Cruaud C, Maciazek J, Weissenbach J, Bousser MG, Bach JF, Tournier-Lasserve E (1997) Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet 350:1511-1515 (Pubitemid 28036555)
12. Chabriat H, Vahedi K, Bousser MG, Iba-Zizen MT, Joutel A, Nibbio A, Nagy TG, Tournier Lasserve E, Krebs MO, Julien J, Ducrocq X, LevasseurM,Mas JL, Dubois B, Homeyer P, Lyon-Caen O (1995) Clinical spectrum of CADASIL: a study of 7 families. Lancet 346:934-939
13. Ruchoux MM, Guerouaou D, Vandenhaute B, Pruvo JP, Vermersch P, Leys D (1995) Systemic vascular smooth muscle cell impairment in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Acta Neuropathol 89:500-512
14. Ihalainen S, Soliymani R, Iivanainen E, Mykkänen K, Sainio A, Pöyhönen M, Elenius K, Järveläinen H, Viitanen M, Kalimo H, Baumann M (2007) Proteome analysis of cultivated vascular smooth muscle cells from a CADASIL patient. Mol Med 13:305-314 (Pubitemid 47175040)
15. Chamorro A (2004) Role of inflammation in stroke and atherothrombosis. Cerebrovasc Dis 17:1-5
16. von Zglinicki T (2002) Oxidative stress shortens telomeres. Trends Biochem Sci 27:339-344
17. Guachalla LM, Rudolph KL (2010) ROS induced DNA damage and checkpoint responses: influences on aging? Cell Cycle 9:4058-4060
18. Reisberg B, Ferris SH, de Leon MJ, Crook T (1982) The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 139:1136-1139 (Pubitemid 12051593)
19. Cawthon RM (2002) Telomere measurement by quantitative PCR. Nucleic Acids Res 30:e47
20. Cawthon RM (2009) Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res 37:e21
21. Chabriat H, Pappata S, Ostergaard L, Clark CA, Pachot-Clouard M, Vahedi K, Jobert A, Le Bihan D, Bousser MG (2000) Cerebral hemodynamics in CADASIL before and after acetazolamide challenge assessed with MRI bolus tracking. Stroke 31:1904-1912 (Pubitemid 30620471)
22. Stromillo ML, Dotti MT, Battaglini M, Mortilla M, Bianchi S, Plewnia K, Pantoni L, Inzitari D, Federico A, De Stefano N (2009) Structural and metabolic brain abnormalities in preclinical cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy. J Neurol Neurosurg Psychiatry 80:41-47
23. Formichi P, Radi E, Battisti C, Di Maio G, Tarquini E, Leonini A, Di Stefano A, Dotti MT, Federico A (2009) Apoptosis in CADASIL: an in vitro study of lymphocytes and fibroblasts from a cohort of Italian patients. J Cell Physiol 219:494-502
24. Houben JM, Moonen HJ, van Schooten FJ, Hageman GJ (2008) Telomere length assessment: biomarker of chronic oxidative stress? Free Radic Biol Med 44(3):235-246
25. Butt HZ, Atturu G, London NJ, Sayers RD, Bown MJ (2010) Telomere length dynamics in vascular disease: a review. Eur J Vasc Endovasc Surg 40(1):17-26
26. Minamino T, Komuro I (2002) Role of telomere in endothelial dysfunction in atherosclerosis. Curr Opin Lipidol 13(5):537-543 (Pubitemid 35231934)
27. Matthews C, Gorenne I, Scott S, Figg N, Kirkpatrick P, Ritchie A, Goddard M, Bennett M (2006) Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress. Circ Res 99(2):156-164 (Pubitemid 44297039)
28. Campa VM, Gutiérrez-Lanza R, Cerignoli F, Díaz-Trelles R, Nelson B, Tsuji T, Barcova M, Jiang W, Mercola M (2008) Notch activates cell cycle reentry and progression in quiescent cardiomyocytes. J Cell Biol 183(1):129-141
29. Grabowski P, Hultdin M, Karlsson K, Tobin G, Aleskog A, Thunberg U, Laurell A, Sundström C, Rosenquist R, Roos G (2005) Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to VH gene mutation status. Blood 105:4807-4812 (Pubitemid 40807307)